Florida Senate - 2005                      COMMITTEE AMENDMENT
    Bill No. SB 874
                        Barcode 511148
                            CHAMBER ACTION
              Senate                               House
                                   .                    
                                   .                    
 1                                 .                    
                                   .                    
 2                                 .                    
                                   .                    
 3                                 .                    
                                   .                    
 4  ______________________________________________________________
 5  
 6  
 7  
 8  
 9  
10  ______________________________________________________________
11  The Committee on Health Care (Peaden) recommended the
12  following amendment:
13  
14         Senate Amendment (with title amendment) 
15         Delete everything after the enacting clause
16  
17  and insert:  
18         Section 1.  Subsection (31) of section 499.003, Florida
19  Statutes, is amended to read:
20         499.003  Definitions of terms used in ss.
21  499.001-499.081.--As used in ss. 499.001-499.081, the term:
22         (31)  "Pedigree paper" means:
23         (a)  A document required pursuant to s. 499.0121(6)(d)
24  or (e); or
25         (b)  Effective July 1, 2006, a document or electronic
26  in a form approved by the Department of Health and containing
27  information that records each distribution of any given legend
28  drug, from sale by a pharmaceutical manufacturer, through
29  acquisition and sale by any wholesaler or repackager, until
30  final sale to a pharmacy or other person administering or
31  dispensing the drug. The information required to be included
                                  1
    12:11 PM   04/08/05                            s0874d-he02-t6r

Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 on a legend drug's pedigree paper must at least detail the 2 amount of the legend drug;, its dosage form and strength;, its 3 lot numbers;, the name and address of each owner of the legend 4 drug and his or her signature;, its shipping information, 5 including the name and address of each person certifying 6 delivery or receipt of the legend drug; an invoice number, a 7 shipping document number, or another number uniquely 8 identifying the transaction;, and a certification that the 9 recipient wholesaler has authenticated the pedigree papers. If 10 the manufacturer or repackager has uniquely serialized the 11 individual legend drug unit, that identifier must also be 12 included on the pedigree. It must also include the name, 13 address, telephone number and, if available, e-mail contact 14 information of each wholesaler involved in the chain of the 15 legend drug's custody. The department shall adopt rules and a 16 form relating to the requirements of this paragraph no later 17 than 90 days after the effective date of this act. 18 Section 2. Paragraph (a) of subsection (1) of section 19 499.012, Florida Statutes, is amended to read: 20 499.012 Wholesale distribution; definitions; permits; 21 applications; general requirements.-- 22 (1) As used in this section, the term: 23 (a) "Wholesale distribution" means distribution of 24 prescription drugs to persons other than a consumer or 25 patient, but does not include: 26 1. Any of the following activities, which is not a 27 violation of s. 499.005(21) if such activity is conducted in 28 accordance with s. 499.014: 29 a. The purchase or other acquisition by a hospital or 30 other health care entity that is a member of a group 31 purchasing organization of a prescription drug for its own use 2 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 from the group purchasing organization or from other hospitals 2 or health care entities that are members of that organization. 3 b. The sale, purchase, or trade of a prescription drug 4 or an offer to sell, purchase, or trade a prescription drug by 5 a charitable organization described in s. 501(c)(3) of the 6 Internal Revenue Code of 1986, as amended and revised, to a 7 nonprofit affiliate of the organization to the extent 8 otherwise permitted by law. 9 c. The sale, purchase, or trade of a prescription drug 10 or an offer to sell, purchase, or trade a prescription drug 11 among hospitals or other health care entities that are under 12 common control. For purposes of this section, "common control" 13 means the power to direct or cause the direction of the 14 management and policies of a person or an organization, 15 whether by ownership of stock, by voting rights, by contract, 16 or otherwise. 17 d. The sale, purchase, trade, or other transfer of a 18 prescription drug from or for any federal, state, or local 19 government agency or any entity eligible to purchase 20 prescription drugs at public health services prices pursuant 21 to Pub. L. No. 102-585, s. 602 to a contract provider or its 22 subcontractor for eligible patients of the agency or entity 23 under the following conditions: 24 (I) The agency or entity must obtain written 25 authorization for the sale, purchase, trade, or other transfer 26 of a prescription drug under this sub-subparagraph from the 27 Secretary of Health or his or her designee. 28 (II) The contract provider or subcontractor must be 29 authorized by law to administer or dispense prescription 30 drugs. 31 (III) In the case of a subcontractor, the agency or 3 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 entity must be a party to and execute the subcontract. 2 (IV) A contract provider or subcontractor must 3 maintain separate and apart from other prescription drug 4 inventory any prescription drugs of the agency or entity in 5 its possession. 6 (V) The contract provider and subcontractor must 7 maintain and produce immediately for inspection all records of 8 movement or transfer of all the prescription drugs belonging 9 to the agency or entity, including, but not limited to, the 10 records of receipt and disposition of prescription drugs. Each 11 contractor and subcontractor dispensing or administering these 12 drugs must maintain and produce records documenting the 13 dispensing or administration. Records that are required to be 14 maintained include, but are not limited to, a perpetual 15 inventory itemizing drugs received and drugs dispensed by 16 prescription number or administered by patient identifier, 17 which must be submitted to the agency or entity quarterly. 18 (VI) The contract provider or subcontractor may 19 administer or dispense the prescription drugs only to the 20 eligible patients of the agency or entity or must return the 21 prescription drugs for or to the agency or entity. The 22 contract provider or subcontractor must require proof from 23 each person seeking to fill a prescription or obtain treatment 24 that the person is an eligible patient of the agency or entity 25 and must, at a minimum, maintain a copy of this proof as part 26 of the records of the contractor or subcontractor required 27 under sub-sub-subparagraph (V). 28 (VII) In addition to the departmental inspection 29 authority set forth in s. 499.051, the establishment of the 30 contract provider and subcontractor and all records pertaining 31 to prescription drugs subject to this sub-subparagraph shall 4 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 be subject to inspection by the agency or entity. All records 2 relating to prescription drugs of a manufacturer under this 3 sub-subparagraph shall be subject to audit by the manufacturer 4 of those drugs, without identifying individual patient 5 information. 6 2. Any of the following activities, which is not a 7 violation of s. 499.005(21) if such activity is conducted in 8 accordance with rules established by the department: 9 a. The sale, purchase, or trade of a prescription drug 10 among federal, state, or local government health care entities 11 that are under common control and are authorized to purchase 12 such prescription drug. 13 b. The sale, purchase, or trade of a prescription drug 14 or an offer to sell, purchase, or trade a prescription drug 15 for emergency medical reasons. For purposes of this 16 sub-subparagraph, the term "emergency medical reasons" 17 includes transfers of prescription drugs by a retail pharmacy 18 to another retail pharmacy to alleviate a temporary shortage. 19 c. The transfer of a prescription drug acquired by a 20 medical director on behalf of a licensed emergency medical 21 services provider to that emergency medical services provider 22 and its transport vehicles for use in accordance with the 23 provider's license under chapter 401. 24 d. The revocation of a sale or the return of a 25 prescription drug to the person's prescription drug wholesale 26 supplier. 27 e. The donation of a prescription drug by a health 28 care entity to a charitable organization that has been granted 29 an exemption under s. 501(c)(3) of the Internal Revenue Code 30 of 1986, as amended, and that is authorized to possess 31 prescription drugs. 5 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 f. The transfer of a prescription drug by a person 2 authorized to purchase or receive prescription drugs to a 3 person licensed or permitted to handle reverse distributions 4 or destruction under the laws of the jurisdiction in which the 5 person handling the reverse distribution or destruction 6 receives the drug. 7 g. The transfer of a prescription drug by a hospital 8 or other health care entity to a person licensed under this 9 chapter to repackage prescription drugs for the purpose of 10 repackaging the prescription drug for use by that hospital, or 11 other health care entity and other health care entities that 12 are under common control, if ownership of the prescription 13 drugs remains with the hospital or other health care entity at 14 all times. In addition to the recordkeeping requirements of 15 s. 499.0121(6), the hospital or health care entity that 16 transfers prescription drugs pursuant to this sub-subparagraph 17 must reconcile all drugs transferred and returned and resolve 18 any discrepancies in a timely manner. 19 3. The distribution of prescription drug samples by 20 manufacturers' representatives or distributors' 21 representatives conducted in accordance with s. 499.028. 22 4. The sale, purchase, or trade of blood and blood 23 components intended for transfusion. As used in this 24 subparagraph, the term "blood" means whole blood collected 25 from a single donor and processed either for transfusion or 26 further manufacturing, and the term "blood components" means 27 that part of the blood separated by physical or mechanical 28 means. 29 5. The lawful dispensing of a prescription drug in 30 accordance with chapter 465. 31 6. The sale, purchase, or trade of a prescription drug 6 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 between pharmacies as a result of a sale, transfer, merger, or 2 consolidation of all or part of the business of the pharmacies 3 from or with another pharmacy, whether accomplished as a 4 purchase and sale of stock or of business assets. 5 Section 3. Paragraph (h) of subsection (6) of section 6 499.0121, Florida Statutes, is amended to read: 7 499.0121 Storage and handling of prescription drugs; 8 recordkeeping.--The department shall adopt rules to implement 9 this section as necessary to protect the public health, 10 safety, and welfare. Such rules shall include, but not be 11 limited to, requirements for the storage and handling of 12 prescription drugs and for the establishment and maintenance 13 of prescription drug distribution records. 14 (6) RECORDKEEPING.--The department shall adopt rules 15 that require keeping such records of prescription drugs as are 16 necessary for the protection of the public health. 17 (h)1. This paragraph applies only to an affiliated 18 group, as defined by s. 1504 of the Internal Revenue Code of 19 1986, as amended, which is composed of chain drug entities, 20 including at least 50 retail pharmacies, warehouses, or 21 repackagers, which are members of the same affiliated group, 22 if the affiliated group: 23 a. Discloses to the department the names of all its 24 members; and 25 b. Agrees in writing to provide records on 26 prescription drug purchases by members of the affiliated group 27 not later than 48 hours after the department requests such 28 records, regardless of the location where the records are 29 stored. 30 2. Each warehouse within the affiliated group must 31 comply with all applicable federal and state drug wholesale 7 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 permit requirements and must purchase, receive, hold, and 2 distribute prescription drugs only to a retail pharmacy or 3 warehouse within the affiliated group. Such a warehouse is 4 exempt from providing a pedigree paper in accordance with 5 paragraphs (d), (e), and (f) (e) to its affiliated group 6 member warehouse or retail pharmacy, provided that: 7 a. Any affiliated group member that purchases or 8 receives a prescription drug from outside the affiliated group 9 must receive a pedigree paper if the prescription drug is 10 distributed in or into this state and a pedigree paper is 11 required under this section and must authenticate the 12 documentation as required in subsection (4), regardless of 13 whether the affiliated group member is directly subject to 14 regulation under this chapter; and 15 b. The affiliated group makes available to the 16 department on request all records related to the purchase or 17 acquisition of prescription drugs by members of the affiliated 18 group, regardless of the location where the records are 19 stored, if the prescription drugs were distributed in or into 20 this state. 21 3. If a repackager repackages prescription drugs 22 solely for distribution to its affiliated group members for 23 the exclusive distribution to and among retail pharmacies that 24 are members of the affiliated group to which the repackager is 25 a member: 26 a. The repackager must: 27 (I) In lieu of the written statement required by 28 paragraph (d), or paragraph (e), or paragraph (f), for all 29 repackaged prescription drugs distributed in or into this 30 state, state in writing under oath with each distribution of a 31 repackaged prescription drug to an affiliated group member 8 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 warehouse or repackager: "All repackaged prescription drugs 2 are purchased by the affiliated group directly from the 3 manufacturer or from a prescription drug wholesaler that 4 purchased the prescription drugs directly from the 5 manufacturer."; 6 (II) Purchase all prescription drugs it repackages: 7 (A) Directly from the manufacturer; or 8 (B) From a prescription drug wholesaler that purchased 9 the prescription drugs directly from the manufacturer; and 10 (III) Maintain records in accordance with this section 11 to document that it purchased the prescription drugs directly 12 from the manufacturer or that its prescription drug wholesale 13 supplier purchased the prescription drugs directly from the 14 manufacturer. 15 b. All members of the affiliated group must provide to 16 agents of the department on request records of purchases by 17 all members of the affiliated group of prescription drugs that 18 have been repackaged, regardless of the location where the 19 records are stored or where the repackager is located. 20 4. This paragraph expires July 1, 2006. 21 Section 4. This act shall take effect upon becoming a 22 law. 23 24 25 ================ T I T L E A M E N D M E N T =============== 26 And the title is amended as follows: 27 Delete everything before the enacting clause 28 29 and insert: 30 A bill to be entitled 31 An act relating to the sale and distribution of 9 12:11 PM 04/08/05 s0874d-he02-t6r
Florida Senate - 2005 COMMITTEE AMENDMENT Bill No. SB 874 Barcode 511148 1 prescription drugs; amending s. 499.003, F.S.; 2 redefining the term "pedigree paper"; amending 3 s. 499.012, F.S.; providing an exemption from 4 wholesale distribution for the transfer of 5 prescription drugs due to a change in the 6 ownership of a pharmacy; amending s. 499.0121, 7 F.S.; abrogating the expiration of 8 recordkeeping provisions for pedigree papers 9 which relate to chain drug entities that are 10 part of an affiliated group; providing an 11 effective date. 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 10 12:11 PM 04/08/05 s0874d-he02-t6r